Sanofi-aventis acquires BMP Sunstone

BMP Sunstone stockholders will now receive $10 per share in cash for common stock shares they owned prior to the effective time of the merger.

Beijing-based BMP Sunstone, through Sunstone, manufactures pediatric and women’s health products sold in pharmacies across the China.

BMP Sunstone also markets a portfolio of products under exclusive multi-year licenses into China, primarily focused on women’s health and pediatrics, as well as provides pharmaceutical distribution services through subsidiaries in Beijing and Shanghai.

The acquisition is a part of sanofi-aventis’ strategy to become a diversified healthcare player in China and create a strong consumer healthcare platform in China by leveraging BMP Sunstone’s established foothold in the cough & cold and women’s health segments.